2023
DOI: 10.3389/fimmu.2023.1249379
|View full text |Cite
|
Sign up to set email alerts
|

Single-cell transcriptomics reveals subtype-specific molecular profiles in Nrf2-deficient macrophages from murine atherosclerotic aortas

Katarzyna Sarad,
Monika Stefańska,
Izabela Kraszewska
et al.

Abstract: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcriptional regulator of antioxidant and anti-inflammatory response in all cell types. It also activates the transcription of genes important for macrophage function. Nrf2 activity declines with age and has been closely linked to atherosclerosis, but its specific role in this vascular pathology is not clear. Atherosclerotic plaques contain several macrophage subsets with distinct, yet not completely understood, functions in the lesion development. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
4
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 80 publications
1
4
0
Order By: Relevance
“…This results in a significant reduction in the accumulation of large Rab5 aggregates in erythroblasts from ATS-NP-treated Nrf2 −/− mice. Of note, we observed a difference in the amounts of ATS detected in the liver and spleen from Nrf2 −/− vs. wild-type mice, which might be related to pro-inflammatory vs. pro-resolving profile of macrophages in the spleen and liver lacking the expression of Nrf2 as previously noted in other disease models [57,58]. Indeed, ATS-NPs reprogram splenic macrophage from a pro-inflammatory to a pro-resolving M2 profile [43].…”
Section: Discussionsupporting
confidence: 70%
See 1 more Smart Citation
“…This results in a significant reduction in the accumulation of large Rab5 aggregates in erythroblasts from ATS-NP-treated Nrf2 −/− mice. Of note, we observed a difference in the amounts of ATS detected in the liver and spleen from Nrf2 −/− vs. wild-type mice, which might be related to pro-inflammatory vs. pro-resolving profile of macrophages in the spleen and liver lacking the expression of Nrf2 as previously noted in other disease models [57,58]. Indeed, ATS-NPs reprogram splenic macrophage from a pro-inflammatory to a pro-resolving M2 profile [43].…”
Section: Discussionsupporting
confidence: 70%
“…In addition, we note that Atg4, 5 and p62 genes also contain the AREsequence, modulated by Nrf2 [54]. Thus, we were not surprised that in sorted Nrf2 −/− erythroblasts, Atg4, 5 and p62 expression was downregulated compared to wild-type cells [20,[55][56][57][58]. This resulted in the accumulation of Rab5 organized in large clusters, supporting the impairment of autophagy in Nrf2 −/− erythroblasts.…”
Section: Discussionmentioning
confidence: 63%
“…reported a subtype-specific expression of core ferroptosis genes (e.g. Cp, Hells, Slc40a1 ) in inflammatory versus tissue-resident macrophages ( 158 ). This observation suggests a link between ferroptosis and inflammatory microenvironment appearing at a very early stage of atherogenesis.…”
Section: Cell Death In Atherosclerotic Plaques: Pyroptosis Necroptosi...mentioning
confidence: 99%
“…This observation suggests a link between ferroptosis and inflammatory microenvironment appearing at a very early stage of atherogenesis. Their findings indicate that Nrf2 deficiency in aortic macrophages leads to subtype-specific transcriptomic changes associated with cell death pathways ( 158 ).…”
Section: Cell Death In Atherosclerotic Plaques: Pyroptosis Necroptosi...mentioning
confidence: 99%
“…Micheliolide, an aesquiterpene lactone, inhibits atherosclerosis by activating the NRF2 pathway to inhibit ferroptosis in macrophages [158] . Recently, single-cell transcriptomics revealed that, compared with control aortic macrophages, aortic macrophages from Nrf2 -knockout mice exhibit differential changes in subtype-specific transcriptomes associated with inflammation, iron homeostasis, cell damage, and ferroptosis pathways [189] . Collectively, these findings suggest that NRF2 is a promising therapeutic target for the treatment of AS-related diseases.…”
Section: Ferroptosis Is An Important Potential Treatment Target In Asmentioning
confidence: 99%